메뉴 건너뛰기




Volumn 122, Issue , 2016, Pages 102-117

Discovery and development of natural product oridonin-inspired anticancer agents

Author keywords

Anticancer agents; Chemical biology; Diterpenoids; Drug discovery; Natural product; Oridonin

Indexed keywords

ALPHA,BETA UNSATURATED KETONE; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; DITERPENOID; HYDROXYL GROUP; KETONE; NATURAL PRODUCT; ORIDONIN; UNCLASSIFIED DRUG; BIOLOGICAL PRODUCT; BIOMIMETIC MATERIAL; KAURANE DERIVATIVE;

EID: 84976295619     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2016.06.015     Document Type: Review
Times cited : (155)

References (130)
  • 1
    • 14944383798 scopus 로고    scopus 로고
    • The evolving role of natural products in drug discovery
    • [1] Koehn, F.E., Carter, G.T., The evolving role of natural products in drug discovery. Nat. Rev. Drug Discov. 4 (2005), 206–220.
    • (2005) Nat. Rev. Drug Discov. , vol.4 , pp. 206-220
    • Koehn, F.E.1    Carter, G.T.2
  • 2
    • 84926205808 scopus 로고    scopus 로고
    • The re-emergence of natural products for drug discovery in the genomics era
    • [2] Harvey, A.L., Edrada-Ebel, R., Quinn, R.J., The re-emergence of natural products for drug discovery in the genomics era. Nat. Rev. Drug Discov. 14 (2015), 111–129.
    • (2015) Nat. Rev. Drug Discov. , vol.14 , pp. 111-129
    • Harvey, A.L.1    Edrada-Ebel, R.2    Quinn, R.J.3
  • 3
    • 84964698735 scopus 로고    scopus 로고
    • Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents
    • [3] Chen, H., Gao, Y., Wang, A., Zhou, X., Zheng, Y., Zhou, J., Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents. Eur. J. Med. Chem. 92 (2015), 648–655.
    • (2015) Eur. J. Med. Chem. , vol.92 , pp. 648-655
    • Chen, H.1    Gao, Y.2    Wang, A.3    Zhou, X.4    Zheng, Y.5    Zhou, J.6
  • 4
    • 84910006077 scopus 로고    scopus 로고
    • Exploring therapeutic potentials of baicalin and its aglycone baicalin for hematological malignancies
    • [4] Chen, H., Gao, Y., Wu, J., Chen, Y., Chen, B., Hu, J., Zhou, J., Exploring therapeutic potentials of baicalin and its aglycone baicalin for hematological malignancies. Cancer Lett. 354 (2014), 5–11.
    • (2014) Cancer Lett. , vol.354 , pp. 5-11
    • Chen, H.1    Gao, Y.2    Wu, J.3    Chen, Y.4    Chen, B.5    Hu, J.6    Zhou, J.7
  • 5
    • 84962367258 scopus 로고    scopus 로고
    • Natural products as sources of new drugs from 1981 to 2014
    • PMID: 26718746
    • [5] Newman, D.J., Cragg, G.M., Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod., 2016, 10.1021/acs.jnatprod.5b01055 PMID: 26718746.
    • (2016) J. Nat. Prod.
    • Newman, D.J.1    Cragg, G.M.2
  • 6
    • 84905495729 scopus 로고    scopus 로고
    • The discovery of first-in-class drugs: origins and evolution
    • [6] Eder, J., Sedrani, R., Wiesmann, C., The discovery of first-in-class drugs: origins and evolution. Nat. Rev. Drug Discov. 13 (2014), 577–587.
    • (2014) Nat. Rev. Drug Discov. , vol.13 , pp. 577-587
    • Eder, J.1    Sedrani, R.2    Wiesmann, C.3
  • 7
    • 80052937334 scopus 로고    scopus 로고
    • Artemisinin: discovery from the Chinese herbal garden
    • [7] Miller, L.H., Su, X., Artemisinin: discovery from the Chinese herbal garden. Cell 146 (2011), 855–858.
    • (2011) Cell , vol.146 , pp. 855-858
    • Miller, L.H.1    Su, X.2
  • 8
    • 84944174789 scopus 로고    scopus 로고
    • Anti-parasite drugs sweep Nobel prize in medicine 2015
    • [8] Callaway, E., Cyranoski, D., Anti-parasite drugs sweep Nobel prize in medicine 2015. Nature 526 (2015), 174–175.
    • (2015) Nature , vol.526 , pp. 174-175
    • Callaway, E.1    Cyranoski, D.2
  • 10
    • 76849087811 scopus 로고    scopus 로고
    • Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer
    • [10] Bedard, P.L., Di, L.A., Piccart-Gebhart, M.J., Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer. Nat. Rev. Clin. Oncol. 7 (2010), 22–36.
    • (2010) Nat. Rev. Clin. Oncol. , vol.7 , pp. 22-36
    • Bedard, P.L.1    Di, L.A.2    Piccart-Gebhart, M.J.3
  • 11
    • 49949133123 scopus 로고
    • Diterpenoid constituents of Isodon trichocarpus and Isodon japonicus (terpenoids IV)
    • [11] Fujita, E., Fujita, T., Shibuya, M., Diterpenoid constituents of Isodon trichocarpus and Isodon japonicus (terpenoids IV). Tetrahedron Lett. 7 (1966), 3153–3162.
    • (1966) Tetrahedron Lett. , vol.7 , pp. 3153-3162
    • Fujita, E.1    Fujita, T.2    Shibuya, M.3
  • 13
    • 0017172723 scopus 로고
    • The antitumor and antibacterial activity of the Isodon diterpenoids
    • [13] Fujita, E., Nagao, Y., Kaneko, K., Nakazawa, S., Kuroda, H., The antitumor and antibacterial activity of the Isodon diterpenoids. Chem. Pharm. Bull. 24 (1976), 2118–2127.
    • (1976) Chem. Pharm. Bull. , vol.24 , pp. 2118-2127
    • Fujita, E.1    Nagao, Y.2    Kaneko, K.3    Nakazawa, S.4    Kuroda, H.5
  • 14
    • 85043181998 scopus 로고    scopus 로고
    • L-alanine-(14-oridonin) ester trifluoroacetate as well as preparation method and application, Chinese Patent (2014) CN 104017000 A.
    • [14] P.Y. Sun, G.L. Wu, Z.J. Qiu, Y.J. Chen, L-alanine-(14-oridonin) ester trifluoroacetate as well as preparation method and application, Chinese Patent (2014) CN 104017000 A.
    • Sun, P.Y.1    Wu, G.L.2    Qiu, Z.J.3    Chen, Y.J.4
  • 16
    • 70350624803 scopus 로고    scopus 로고
    • Efficacy of Rabdosia rubescens in the treatment of gingivitis
    • [16] Chen, S., Liu, J., Zhang, H., Efficacy of Rabdosia rubescens in the treatment of gingivitis. J. Huazhong Univ. Sci. Technol. Med. Sci. 29 (2009), 659–663.
    • (2009) J. Huazhong Univ. Sci. Technol. Med. Sci. , vol.29 , pp. 659-663
    • Chen, S.1    Liu, J.2    Zhang, H.3
  • 17
    • 79952914222 scopus 로고    scopus 로고
    • Therapeutic effect of Rabdosia rubescens aqueous extract on chronic pharyngitis and its safety
    • [17] Ma, Z., Hu, C., Zhang, Y., Therapeutic effect of Rabdosia rubescens aqueous extract on chronic pharyngitis and its safety. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 36 (2011), 170–173.
    • (2011) Zhong Nan Da Xue Xue Bao Yi Xue Ban. , vol.36 , pp. 170-173
    • Ma, Z.1    Hu, C.2    Zhang, Y.3
  • 19
    • 47849123320 scopus 로고    scopus 로고
    • Inflammatory aortitis controlled by the Chinese herbal remedy Donglingcao Pian
    • [19] De Silva, C., Stevens, R., Jordan, K.M., Inflammatory aortitis controlled by the Chinese herbal remedy Donglingcao Pian. Rheumatology 47 (2008), 1257–1259.
    • (2008) Rheumatology , vol.47 , pp. 1257-1259
    • De Silva, C.1    Stevens, R.2    Jordan, K.M.3
  • 20
    • 1642540641 scopus 로고    scopus 로고
    • Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells
    • [20] Ikezoe, T., Chen, S.S., Tong, X.J., Heber, D., Taguchi, H., Koeffler, H.P., Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells. Int. J. Oncol. 23 (2003), 1187–1193.
    • (2003) Int. J. Oncol. , vol.23 , pp. 1187-1193
    • Ikezoe, T.1    Chen, S.S.2    Tong, X.J.3    Heber, D.4    Taguchi, H.5    Koeffler, H.P.6
  • 21
    • 23044504665 scopus 로고    scopus 로고
    • Novel mechanism of inhibition of nuclear factor-kappa B DNA-binding activity by diterpenoids isolated from Isodon rubescens
    • [21] Leung, C.H., Grill, S.P., Lam, W., Han, Q.B., Sun, H.D., Cheng, Y.C., Novel mechanism of inhibition of nuclear factor-kappa B DNA-binding activity by diterpenoids isolated from Isodon rubescens. Mol. Pharmacol. 68 (2005), 286–297.
    • (2005) Mol. Pharmacol. , vol.68 , pp. 286-297
    • Leung, C.H.1    Grill, S.P.2    Lam, W.3    Han, Q.B.4    Sun, H.D.5    Cheng, Y.C.6
  • 22
    • 25844511169 scopus 로고    scopus 로고
    • Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the Chinese herb Rabdosia rubescens
    • [22] Hsieh, T.C., Wijeratne, E.K., Liang, J.Y., Gunatilaka, A.L., Wu, J.M., Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the Chinese herb Rabdosia rubescens. Biochem. Biophys. Res. Commun. 337 (2005), 224–231.
    • (2005) Biochem. Biophys. Res. Commun. , vol.337 , pp. 224-231
    • Hsieh, T.C.1    Wijeratne, E.K.2    Liang, J.Y.3    Gunatilaka, A.L.4    Wu, J.M.5
  • 23
    • 84925880439 scopus 로고    scopus 로고
    • Oridonin, a promising antitumor natural product in the chemotherapy of hematological malignancies
    • [23] Zhao, Z., Chen, Y., Oridonin, a promising antitumor natural product in the chemotherapy of hematological malignancies. Curr. Pharm. Biotechnol. 15 (2014), 1083–1092.
    • (2014) Curr. Pharm. Biotechnol. , vol.15 , pp. 1083-1092
    • Zhao, Z.1    Chen, Y.2
  • 24
    • 84885574287 scopus 로고    scopus 로고
    • Recent advances in the molecular basis of anti-neoplastic mechanisms of oridonin
    • [24] Tian, W., Chen, S.Y., Recent advances in the molecular basis of anti-neoplastic mechanisms of oridonin. Chin. J. Integr. Med. 19 (2013), 315–320.
    • (2013) Chin. J. Integr. Med. , vol.19 , pp. 315-320
    • Tian, W.1    Chen, S.Y.2
  • 25
    • 84868142361 scopus 로고    scopus 로고
    • Oridonin: targeting programmed cell death pathways as an anti-tumour agent
    • [25] Liu, Z., Ouyang, L., Peng, H., Zhang, W.Z., Oridonin: targeting programmed cell death pathways as an anti-tumour agent. Cell Prolif. 45 (2012), 499–507.
    • (2012) Cell Prolif. , vol.45 , pp. 499-507
    • Liu, Z.1    Ouyang, L.2    Peng, H.3    Zhang, W.Z.4
  • 26
    • 79953029230 scopus 로고    scopus 로고
    • Oridonin: an active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics
    • [26] Li, C.Y., Wang, E.Q., Cheng, Y., Bao, J.K., Oridonin: an active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics. Int. J. Biochem. Cell Biol. 43 (2011), 701–704.
    • (2011) Int. J. Biochem. Cell Biol. , vol.43 , pp. 701-704
    • Li, C.Y.1    Wang, E.Q.2    Cheng, Y.3    Bao, J.K.4
  • 28
    • 34147131374 scopus 로고    scopus 로고
    • Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo
    • [28] Zhou, G.B., Kang, H., Wang, L., Gao, L., Liu, P., Xie, J., Zhang, F.X., Weng, X.Q., Shen, Z.X., Chen, J., Gu, L.J., Yan, M., Zhang, D.E., Chen, S.J., Wang, Z.Y., Chen, Z., Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo. Blood 109 (2007), 3441–3450.
    • (2007) Blood , vol.109 , pp. 3441-3450
    • Zhou, G.B.1    Kang, H.2    Wang, L.3    Gao, L.4    Liu, P.5    Xie, J.6    Zhang, F.X.7    Weng, X.Q.8    Shen, Z.X.9    Chen, J.10    Gu, L.J.11    Yan, M.12    Zhang, D.E.13    Chen, S.J.14    Wang, Z.Y.15    Chen, Z.16
  • 29
    • 84905995986 scopus 로고    scopus 로고
    • Inhibition of miR-17 and miR-20a by oridonin triggers apoptosis and reverses chemoresistance by derepressing BIM-S
    • [29] Weng, H., Huang, H., Dong, B., Zhao, P., Zhou, H., Qu, L., Inhibition of miR-17 and miR-20a by oridonin triggers apoptosis and reverses chemoresistance by derepressing BIM-S. Cancer Res. 74 (2014), 4409–4419.
    • (2014) Cancer Res. , vol.74 , pp. 4409-4419
    • Weng, H.1    Huang, H.2    Dong, B.3    Zhao, P.4    Zhou, H.5    Qu, L.6
  • 30
    • 84862731787 scopus 로고    scopus 로고
    • Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis
    • [30] Huang, H.L., Weng, H.Y., Wang, L.Q., Yu, C.H., Huang, Q.J., Zhao, P.P., Wen, J.Z., Zhou, H., Qu, L.H., Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis. Mol. Cancer. Ther. 11 (2012), 1155–1165.
    • (2012) Mol. Cancer. Ther. , vol.11 , pp. 1155-1165
    • Huang, H.L.1    Weng, H.Y.2    Wang, L.Q.3    Yu, C.H.4    Huang, Q.J.5    Zhao, P.P.6    Wen, J.Z.7    Zhou, H.8    Qu, L.H.9
  • 31
    • 18044387257 scopus 로고    scopus 로고
    • Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways
    • [31] Ikezoe, T., Yang, Y., Bandobashi, K., Saito, T., Takemoto, S., Machida, H., Togitani, K., Koeffler, H.P., Taguchi, H., Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways. Mol. Cancer Ther. 4 (2005), 578–586.
    • (2005) Mol. Cancer Ther. , vol.4 , pp. 578-586
    • Ikezoe, T.1    Yang, Y.2    Bandobashi, K.3    Saito, T.4    Takemoto, S.5    Machida, H.6    Togitani, K.7    Koeffler, H.P.8    Taguchi, H.9
  • 32
    • 65249128643 scopus 로고    scopus 로고
    • Molecular mechanisms of oridonin-induced apoptosis and autophagy in murine fibrosarcoma L929 cells
    • [32] Cheng, Y., Qiu, F., Ikejima, T., Molecular mechanisms of oridonin-induced apoptosis and autophagy in murine fibrosarcoma L929 cells. Autophagy 5 (2009), 430–431.
    • (2009) Autophagy , vol.5 , pp. 430-431
    • Cheng, Y.1    Qiu, F.2    Ikejima, T.3
  • 33
    • 77953359873 scopus 로고    scopus 로고
    • Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways
    • [33] Kang, N., Zhang, J.H., Qiu, F., Tashiro, S., Onodera, S., Ikejima, T., Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways. Cancer Lett. 294 (2010), 147–158.
    • (2010) Cancer Lett. , vol.294 , pp. 147-158
    • Kang, N.1    Zhang, J.H.2    Qiu, F.3    Tashiro, S.4    Onodera, S.5    Ikejima, T.6
  • 35
    • 84863811994 scopus 로고    scopus 로고
    • Oridonin up-regulates expression of P21 and induces autophagy and apoptosis in human prostate cancer cells
    • [35] Li, X., Li, X., Wang, J., Ye, Z., Li, J.C., Oridonin up-regulates expression of P21 and induces autophagy and apoptosis in human prostate cancer cells. Int. J. Biol. Sci. 8 (2012), 901–912.
    • (2012) Int. J. Biol. Sci. , vol.8 , pp. 901-912
    • Li, X.1    Li, X.2    Wang, J.3    Ye, Z.4    Li, J.C.5
  • 36
    • 84880994584 scopus 로고    scopus 로고
    • The anticancer effect of oridonin is mediated by fatty acid synthase suppression in human colorectal cancer cells
    • [36] Kwan, H.Y., Yang, Z., Fong, W.F., Hu, Y.M., Yu, Z.L., Hsiao, W.L., The anticancer effect of oridonin is mediated by fatty acid synthase suppression in human colorectal cancer cells. J. Gastroenterol. 48 (2013), 182–192.
    • (2013) J. Gastroenterol. , vol.48 , pp. 182-192
    • Kwan, H.Y.1    Yang, Z.2    Fong, W.F.3    Hu, Y.M.4    Yu, Z.L.5    Hsiao, W.L.6
  • 37
    • 84907943686 scopus 로고    scopus 로고
    • Polypharmacology: challenges and opportunities in drug discovery
    • [37] Anighoro, A., Bajorath, J., Rastelli, G., Polypharmacology: challenges and opportunities in drug discovery. J. Med. Chem. 57 (2014), 7874–7887.
    • (2014) J. Med. Chem. , vol.57 , pp. 7874-7887
    • Anighoro, A.1    Bajorath, J.2    Rastelli, G.3
  • 38
    • 84871967576 scopus 로고    scopus 로고
    • Polypharmacology: drug discovery for the future
    • [38] Reddy, A.S., Zhang, S., Polypharmacology: drug discovery for the future. Expert Rev. Clin. Pharmacol. 6 (2013), 41–47.
    • (2013) Expert Rev. Clin. Pharmacol. , vol.6 , pp. 41-47
    • Reddy, A.S.1    Zhang, S.2
  • 39
    • 60349085032 scopus 로고    scopus 로고
    • Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-kappa B survival pathways in oridonin-treated murine fibrosarcoma L929 cells
    • [39] Cheng, Y., Qiu, F., Ye, Y.C., Guo, Z.M., Tashiro, S., Onodera, S., Ikejima, T., Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-kappa B survival pathways in oridonin-treated murine fibrosarcoma L929 cells. FEBS J. 276 (2009), 1291–1306.
    • (2009) FEBS J. , vol.276 , pp. 1291-1306
    • Cheng, Y.1    Qiu, F.2    Ye, Y.C.3    Guo, Z.M.4    Tashiro, S.5    Onodera, S.6    Ikejima, T.7
  • 40
    • 54149084936 scopus 로고    scopus 로고
    • Oridonin confers protection against arsenic-induced toxicity through activation of the Nrf2-mediated defensive response
    • [40] Du, Y., Villeneuve, N.F., Wang, X.J., Sun, Z., Chen, W., Li, J., Lou, H., Wong, P.K., Zhang, D.D., Oridonin confers protection against arsenic-induced toxicity through activation of the Nrf2-mediated defensive response. Environ. Health Persp. 116 (2008), 1154–1161.
    • (2008) Environ. Health Persp. , vol.116 , pp. 1154-1161
    • Du, Y.1    Villeneuve, N.F.2    Wang, X.J.3    Sun, Z.4    Chen, W.5    Li, J.6    Lou, H.7    Wong, P.K.8    Zhang, D.D.9
  • 41
    • 84891146250 scopus 로고    scopus 로고
    • Oridonin ameliorates neuropathological changes and behavioural deficits in a mouse model of cerebral amyloidosis
    • [41] Zhang, Z.Y., Daniels, R., Schluesener, H.J., Oridonin ameliorates neuropathological changes and behavioural deficits in a mouse model of cerebral amyloidosis. J. Cell Mol. Med. 17 (2013), 1566–1576.
    • (2013) J. Cell Mol. Med. , vol.17 , pp. 1566-1576
    • Zhang, Z.Y.1    Daniels, R.2    Schluesener, H.J.3
  • 42
    • 84905983897 scopus 로고    scopus 로고
    • Oridonin attenuates Aβ1–42-induced neuroinflammation and inhibits NF-κB pathway
    • [42] Wang, S., Yang, H., Yu, L., Jin, J., Qian, L., Zhao, H., Xu, Y., Zhu, X., Oridonin attenuates Aβ1–42-induced neuroinflammation and inhibits NF-κB pathway. PLoS One, 9, 2014, e104745.
    • (2014) PLoS One , vol.9 , pp. e104745
    • Wang, S.1    Yang, H.2    Yu, L.3    Jin, J.4    Qian, L.5    Zhao, H.6    Xu, Y.7    Zhu, X.8
  • 43
    • 84867034260 scopus 로고    scopus 로고
    • Role of nrf2 in oxidative stress and toxicity
    • [43] Ma, Q., Role of nrf2 in oxidative stress and toxicity. Annu. Rev. Pharmacol. Toxicol. 53 (2013), 401–426.
    • (2013) Annu. Rev. Pharmacol. Toxicol. , vol.53 , pp. 401-426
    • Ma, Q.1
  • 44
    • 84892441231 scopus 로고    scopus 로고
    • Screening of natural compounds as activators of the keap1-nrf2 pathway
    • [44] Wu, K.C., McDonald, P.R., Liu, J., Klaassen, C.D., Screening of natural compounds as activators of the keap1-nrf2 pathway. Planta Med. 80 (2014), 97–104.
    • (2014) Planta Med. , vol.80 , pp. 97-104
    • Wu, K.C.1    McDonald, P.R.2    Liu, J.3    Klaassen, C.D.4
  • 45
    • 33847050801 scopus 로고    scopus 로고
    • Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway
    • [45] Kensler, T.W., Wakabayashi, N., Biswal, S., Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 47 (2007), 89–116.
    • (2007) Annu. Rev. Pharmacol. Toxicol. , vol.47 , pp. 89-116
    • Kensler, T.W.1    Wakabayashi, N.2    Biswal, S.3
  • 47
    • 84864348569 scopus 로고    scopus 로고
    • NRF2 and cancer: the good, the bad and the importance of context
    • [47] Sporn, M.B., Liby, K.T., NRF2 and cancer: the good, the bad and the importance of context. Nat. Rev. Cancer 12 (2012), 564–571.
    • (2012) Nat. Rev. Cancer , vol.12 , pp. 564-571
    • Sporn, M.B.1    Liby, K.T.2
  • 48
    • 84867041441 scopus 로고    scopus 로고
    • Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2
    • [48] Ma, Q., He, X., Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2. Pharmacol. Rev. 64 (2012), 1055–1081.
    • (2012) Pharmacol. Rev. , vol.64 , pp. 1055-1081
    • Ma, Q.1    He, X.2
  • 49
    • 33751361646 scopus 로고    scopus 로고
    • Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma
    • [49] Xu, W., Sun, J., Zhang, T.T., Ma, B., Cui, S.M., Chen, D.W., He, Z.G., Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma. Acta Pharmacol. Sin. 27 (2006), 1642–1646.
    • (2006) Acta Pharmacol. Sin. , vol.27 , pp. 1642-1646
    • Xu, W.1    Sun, J.2    Zhang, T.T.3    Ma, B.4    Cui, S.M.5    Chen, D.W.6    He, Z.G.7
  • 50
    • 48649094535 scopus 로고    scopus 로고
    • Synthesis and biological evaluation of novel 1-O- and 14-O-derivatives of oridonin as potential anticancer drug candidates
    • [50] Xu, J., Yang, J., Ran, Q., Wang, L., Liu, J., Wang, Z., Wu, X., Hua, W., Yuan, S., Zhang, L., Shen, M., Ding, Y., Synthesis and biological evaluation of novel 1-O- and 14-O-derivatives of oridonin as potential anticancer drug candidates. Bioorg. Med. Chem. Lett. 18 (2008), 4741–4744.
    • (2008) Bioorg. Med. Chem. Lett. , vol.18 , pp. 4741-4744
    • Xu, J.1    Yang, J.2    Ran, Q.3    Wang, L.4    Liu, J.5    Wang, Z.6    Wu, X.7    Hua, W.8    Yuan, S.9    Zhang, L.10    Shen, M.11    Ding, Y.12
  • 51
    • 84879588528 scopus 로고    scopus 로고
    • Novel nitrogen-enriched oridonin analogues with thiazole-fused A-ring: protecting group-free synthesis, enhanced anticancer profile, and improved aqueous solubility
    • [51] Ding, C., Zhang, Y., Chen, H., Yang, Z., Wild, C., Chu, L., Liu, H., Shen, Q., Zhou, J., Novel nitrogen-enriched oridonin analogues with thiazole-fused A-ring: protecting group-free synthesis, enhanced anticancer profile, and improved aqueous solubility. J. Med. Chem. 56 (2013), 5048–5058.
    • (2013) J. Med. Chem. , vol.56 , pp. 5048-5058
    • Ding, C.1    Zhang, Y.2    Chen, H.3    Yang, Z.4    Wild, C.5    Chu, L.6    Liu, H.7    Shen, Q.8    Zhou, J.9
  • 53
    • 49449090229 scopus 로고    scopus 로고
    • Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid
    • [53] Chen, L., Zhang, Y., Kong, X., Lan, E., Huang, Z., Peng, S., Kaufman, D.L., Tian, J., Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid. J. Med. Chem. 51 (2008), 4834–4838.
    • (2008) J. Med. Chem. , vol.51 , pp. 4834-4838
    • Chen, L.1    Zhang, Y.2    Kong, X.3    Lan, E.4    Huang, Z.5    Peng, S.6    Kaufman, D.L.7    Tian, J.8
  • 54
    • 84924666732 scopus 로고    scopus 로고
    • Synthesis of CDDO-amino acid-nitric oxide donor trihybrids as potential antitumor agents against both drug-sensitive and drug-resistant colon cancer
    • [54] Ai, Y., Kang, F., Huang, Z., Xue, X., Lai, Y., Peng, S., Tian, J., Zhang, Y., Synthesis of CDDO-amino acid-nitric oxide donor trihybrids as potential antitumor agents against both drug-sensitive and drug-resistant colon cancer. J. Med. Chem. 58 (2015), 2452–2464.
    • (2015) J. Med. Chem. , vol.58 , pp. 2452-2464
    • Ai, Y.1    Kang, F.2    Huang, Z.3    Xue, X.4    Lai, Y.5    Peng, S.6    Tian, J.7    Zhang, Y.8
  • 55
    • 34250219551 scopus 로고    scopus 로고
    • Novel nitrogen mustard-armed combi-molecules for the selective targeting of epidermal growth factor receptor overexperessing solid tumors: discovery of an unusual structure-activity relationship
    • [55] Rachid, Z., Brahimi, F., Qiu, Q., Williams, C., Hartley, J.M., Hartley, J.A., Jean-Claude, B.J., Novel nitrogen mustard-armed combi-molecules for the selective targeting of epidermal growth factor receptor overexperessing solid tumors: discovery of an unusual structure-activity relationship. J. Med. Chem. 50 (2007), 2605–2608.
    • (2007) J. Med. Chem. , vol.50 , pp. 2605-2608
    • Rachid, Z.1    Brahimi, F.2    Qiu, Q.3    Williams, C.4    Hartley, J.M.5    Hartley, J.A.6    Jean-Claude, B.J.7
  • 56
    • 84889241501 scopus 로고    scopus 로고
    • A selective mitochondrial-targeted chlorambucil with remarkable cytotoxicity in breast and pancreatic cancers
    • [56] Millard, M., Gallagher, J.D., Olenyuk, B.Z., Neamati, N., A selective mitochondrial-targeted chlorambucil with remarkable cytotoxicity in breast and pancreatic cancers. J. Med. Chem. 56 (2013), 9170–9179.
    • (2013) J. Med. Chem. , vol.56 , pp. 9170-9179
    • Millard, M.1    Gallagher, J.D.2    Olenyuk, B.Z.3    Neamati, N.4
  • 57
    • 84862995584 scopus 로고    scopus 로고
    • Synthesis and biological evaluation of novel furozan-based nitric oxide-releasing derivatives of oridonin as potential anti-tumor agents
    • [57] Li, D., Wang, L., Cai, H., Zhang, Y., Xu, J., Synthesis and biological evaluation of novel furozan-based nitric oxide-releasing derivatives of oridonin as potential anti-tumor agents. Molecules 17 (2012), 7556–7568.
    • (2012) Molecules , vol.17 , pp. 7556-7568
    • Li, D.1    Wang, L.2    Cai, H.3    Zhang, Y.4    Xu, J.5
  • 58
    • 84904334900 scopus 로고    scopus 로고
    • Novel hybrids of natural oridonin-bearing nitrogen mustards as potential anticancer drug candidates
    • [58] Xu, S., Pei, L., Wang, C., Zhang, Y.K., Li, D., Yao, H., Wu, X., Chen, Z.S., Sun, Y., Xu, J., Novel hybrids of natural oridonin-bearing nitrogen mustards as potential anticancer drug candidates. ACS Med. Chem. Lett. 5 (2014), 797–802.
    • (2014) ACS Med. Chem. Lett. , vol.5 , pp. 797-802
    • Xu, S.1    Pei, L.2    Wang, C.3    Zhang, Y.K.4    Li, D.5    Yao, H.6    Wu, X.7    Chen, Z.S.8    Sun, Y.9    Xu, J.10
  • 59
    • 84901391079 scopus 로고    scopus 로고
    • Derivation of oridonin with bioreduction-responsive disulfide bond
    • [59] Du, M., Guo, Q., Feng, H., Lu, G., Huang, X., Derivation of oridonin with bioreduction-responsive disulfide bond. Chin. J. Chem. 32 (2014), 448–453.
    • (2014) Chin. J. Chem. , vol.32 , pp. 448-453
    • Du, M.1    Guo, Q.2    Feng, H.3    Lu, G.4    Huang, X.5
  • 61
    • 70349988803 scopus 로고    scopus 로고
    • PEG conjugates in clinical development or use as anticancer agents: an overview
    • [61] Pasut, G., Veronese, F.M., PEG conjugates in clinical development or use as anticancer agents: an overview. Adv. Drug Deliv. Rev. 61 (2009), 1177–1188.
    • (2009) Adv. Drug Deliv. Rev. , vol.61 , pp. 1177-1188
    • Pasut, G.1    Veronese, F.M.2
  • 62
    • 0035816168 scopus 로고    scopus 로고
    • PEG drugs: an overview
    • [62] Greenwald, R.B., PEG drugs: an overview. J. Control. Release 74 (2001), 159–171.
    • (2001) J. Control. Release , vol.74 , pp. 159-171
    • Greenwald, R.B.1
  • 63
    • 84861468033 scopus 로고    scopus 로고
    • Biodegradable self-assembled MPEG-PCL micelles for hydrophobic oridonin delivery in vitro
    • [63] Xue, B., Wang, Y., Tang, X., Xie, P., Wang, Y., Luo, F., Wu, C., Qian, Z., Biodegradable self-assembled MPEG-PCL micelles for hydrophobic oridonin delivery in vitro. J. Biomed. Nanotechnol. 8 (2012), 80–89.
    • (2012) J. Biomed. Nanotechnol. , vol.8 , pp. 80-89
    • Xue, B.1    Wang, Y.2    Tang, X.3    Xie, P.4    Wang, Y.5    Luo, F.6    Wu, C.7    Qian, Z.8
  • 64
    • 84963877901 scopus 로고    scopus 로고
    • Oridonin derivative ameliorates experimental colitis by inhibiting activated T cells and translocation of nuclear factor-kappa B
    • PMID: 26718746
    • [64] Liu, Q.Q., Wang, H.L., Chen, K., Wang, S.B., Xu, Y., Ye, Q., Sun, Y.W., Oridonin derivative ameliorates experimental colitis by inhibiting activated T cells and translocation of nuclear factor-kappa B. J. Dig. Dis., 2015, 10.1111/1751-2980.12314 PMID: 26718746.
    • (2015) J. Dig. Dis.
    • Liu, Q.Q.1    Wang, H.L.2    Chen, K.3    Wang, S.B.4    Xu, Y.5    Ye, Q.6    Sun, Y.W.7
  • 65
    • 84907979062 scopus 로고    scopus 로고
    • ent-Kaurane-based regio- and stereoselective inverse electron demand hetero-Diels-Alder reactions: synthesis of dihydropyran-fused diterpenoids
    • [65] Ding, C., Wang, L., Chen, H., Wild, C., Ye, N., Ding, Y., Wang, T., White, M.A., Shen, Q., Zhou, J., ent-Kaurane-based regio- and stereoselective inverse electron demand hetero-Diels-Alder reactions: synthesis of dihydropyran-fused diterpenoids. Org. Biomol. Chem. 12 (2014), 8442–8452.
    • (2014) Org. Biomol. Chem. , vol.12 , pp. 8442-8452
    • Ding, C.1    Wang, L.2    Chen, H.3    Wild, C.4    Ye, N.5    Ding, Y.6    Wang, T.7    White, M.A.8    Shen, Q.9    Zhou, J.10
  • 66
    • 84887892414 scopus 로고    scopus 로고
    • Oridonin ring A-based diverse constructions of enone functionality: identification of novel dienone analogues effective for highly aggressive breast cancer by inducing apoptosis
    • [66] Ding, C., Zhang, Y., Chen, H., Yang, Z., Wild, C., Ye, N., Ester, C.D., Xiong, A., White, M.A., Shen, Q., Zhou, J., Oridonin ring A-based diverse constructions of enone functionality: identification of novel dienone analogues effective for highly aggressive breast cancer by inducing apoptosis. J. Med. Chem. 56 (2013), 8814–8825.
    • (2013) J. Med. Chem. , vol.56 , pp. 8814-8825
    • Ding, C.1    Zhang, Y.2    Chen, H.3    Yang, Z.4    Wild, C.5    Ye, N.6    Ester, C.D.7    Xiong, A.8    White, M.A.9    Shen, Q.10    Zhou, J.11
  • 67
    • 84880554110 scopus 로고    scopus 로고
    • Overcoming synthetic challenges of oridonin A-ring structural diversification: regio- and stereoselective installation of azides and 1,2,3-triazoles at the C-1, C-2, or C-3 position
    • [67] Ding, C., Zhang, Y., Chen, H., Wild, C., Wang, T., White, M.A., Shen, Q., Zhou, J., Overcoming synthetic challenges of oridonin A-ring structural diversification: regio- and stereoselective installation of azides and 1,2,3-triazoles at the C-1, C-2, or C-3 position. Org. Lett. 15 (2013), 3718–3721.
    • (2013) Org. Lett. , vol.15 , pp. 3718-3721
    • Ding, C.1    Zhang, Y.2    Chen, H.3    Wild, C.4    Wang, T.5    White, M.A.6    Shen, Q.7    Zhou, J.8
  • 68
    • 84904357195 scopus 로고    scopus 로고
    • Profile and potential of ixabepilone in the treatment of pancreatic cancer
    • [68] Smaglo, B.G., Pishvaian, M.J., Profile and potential of ixabepilone in the treatment of pancreatic cancer. Drug Des. Devel. Ther. 8 (2014), 923–930.
    • (2014) Drug Des. Devel. Ther. , vol.8 , pp. 923-930
    • Smaglo, B.G.1    Pishvaian, M.J.2
  • 69
    • 84903738409 scopus 로고    scopus 로고
    • Developments of kinesin spindle protein inhibitors as antitumor agents based on the five-membered heterocycle scaffolds
    • [69] Zhao, G.D., Wan, R.Z., Liu, Z.P., Developments of kinesin spindle protein inhibitors as antitumor agents based on the five-membered heterocycle scaffolds. Curr. Med. Chem. 21 (2014), 2691–2701.
    • (2014) Curr. Med. Chem. , vol.21 , pp. 2691-2701
    • Zhao, G.D.1    Wan, R.Z.2    Liu, Z.P.3
  • 70
    • 79953704034 scopus 로고    scopus 로고
    • Epothilones in the treatment of ovarian cancer
    • [70] Diaz-Padilla, I., Oza, A.M., Epothilones in the treatment of ovarian cancer. Future Oncol. 7 (2011), 559–568.
    • (2011) Future Oncol. , vol.7 , pp. 559-568
    • Diaz-Padilla, I.1    Oza, A.M.2
  • 71
    • 84958900764 scopus 로고    scopus 로고
    • Direct activation of Bax protein for cancer therapy
    • [71] Liu, Z., Ding, Y., Ye, N., Wild, C., Chen, H., Zhou, J., Direct activation of Bax protein for cancer therapy. Med. Res. Rev. 36 (2015), 313–341.
    • (2015) Med. Res. Rev. , vol.36 , pp. 313-341
    • Liu, Z.1    Ding, Y.2    Ye, N.3    Wild, C.4    Chen, H.5    Zhou, J.6
  • 73
    • 84949669843 scopus 로고    scopus 로고
    • BH4 domain of Bcl-2 as a novel target for cancer therapy
    • PMID: 26631752
    • [73] Liu, Z., Wild, C., Ding, Y., Ye, N., Chen, H., Wold, E.A., Zhou, J., BH4 domain of Bcl-2 as a novel target for cancer therapy. Drug Discov. Today, 2015, 10.1016/j.drudis.2015.11.008 PMID: 26631752.
    • (2015) Drug Discov. Today
    • Liu, Z.1    Wild, C.2    Ding, Y.3    Ye, N.4    Chen, H.5    Wold, E.A.6    Zhou, J.7
  • 75
    • 84901393389 scopus 로고    scopus 로고
    • Eribulin mesylate in the management of metastatic breast cancer and other solid cancers: a drug review
    • [75] Polastro, L., Aftimos, P.G., Awada, A., Eribulin mesylate in the management of metastatic breast cancer and other solid cancers: a drug review. Expert Rev. Anticancer Ther. 14 (2014), 649–665.
    • (2014) Expert Rev. Anticancer Ther. , vol.14 , pp. 649-665
    • Polastro, L.1    Aftimos, P.G.2    Awada, A.3
  • 76
    • 33646501280 scopus 로고    scopus 로고
    • A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma, Invest
    • [76] Ajani, J.A., Jiang, Y., Faust, J., Chang, B.B., Ho, L., Yao, J.C., Rousey, S., Dakhil, S., Cherny, R.C., Craig, C., Bleyer, A., A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma, Invest. New Drugs 24 (2006), 353–357.
    • (2006) New Drugs , vol.24 , pp. 353-357
    • Ajani, J.A.1    Jiang, Y.2    Faust, J.3    Chang, B.B.4    Ho, L.5    Yao, J.C.6    Rousey, S.7    Dakhil, S.8    Cherny, R.C.9    Craig, C.10    Bleyer, A.11
  • 77
    • 17144381253 scopus 로고    scopus 로고
    • Alpha,beta-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma
    • [77] Shiraki, T., Kamiya, N., Shiki, S., Kodama, T.S., Kakizuka, A., Jingami, H., Alpha,beta-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 280 (2005), 14145–14153.
    • (2005) J. Biol. Chem. , vol.280 , pp. 14145-14153
    • Shiraki, T.1    Kamiya, N.2    Shiki, S.3    Kodama, T.S.4    Kakizuka, A.5    Jingami, H.6
  • 78
    • 0034597578 scopus 로고    scopus 로고
    • Synthetic oleanane and ursane triterpenoids with modified rings A and C: a series of highly active inhibitors of nitric oxide production in mouse macrophages
    • [78] Honda, T., Rounds, B.V., Bore, L., Finlay, H.J., Favaloro, F.G. Jr., Suh, N., Wang, Y., Sporn, M.B., Gribble, G.W., Synthetic oleanane and ursane triterpenoids with modified rings A and C: a series of highly active inhibitors of nitric oxide production in mouse macrophages. J. Med. Chem. 43 (2000), 4233–4246.
    • (2000) J. Med. Chem. , vol.43 , pp. 4233-4246
    • Honda, T.1    Rounds, B.V.2    Bore, L.3    Finlay, H.J.4    Favaloro, F.G.5    Suh, N.6    Wang, Y.7    Sporn, M.B.8    Gribble, G.W.9
  • 79
    • 84903534871 scopus 로고    scopus 로고
    • Discovery of a series of 2,5-diaminopyrimidine covalent irreversible inhibitors of Bruton's tyrosine kinase with in vivo antitumor activity
    • [79] Li, X., Zuo, Y., Tang, G., Wang, Y., Zhou, Y., Wang, X., Guo, T., Xia, M., Ding, N., Pan, Z., Discovery of a series of 2,5-diaminopyrimidine covalent irreversible inhibitors of Bruton's tyrosine kinase with in vivo antitumor activity. J. Med. Chem. 57 (2014), 5112–5128.
    • (2014) J. Med. Chem. , vol.57 , pp. 5112-5128
    • Li, X.1    Zuo, Y.2    Tang, G.3    Wang, Y.4    Zhou, Y.5    Wang, X.6    Guo, T.7    Xia, M.8    Ding, N.9    Pan, Z.10
  • 80
    • 0348109450 scopus 로고    scopus 로고
    • The growing impact of click chemistry on drug discovery
    • [80] Kolb, H.C., Sharpless, K.B., The growing impact of click chemistry on drug discovery. Drug Discov. Today 8 (2003), 1128–1137.
    • (2003) Drug Discov. Today , vol.8 , pp. 1128-1137
    • Kolb, H.C.1    Sharpless, K.B.2
  • 81
    • 80053528741 scopus 로고    scopus 로고
    • Click chemistry: 1,2,3-triazoles as pharmacophores
    • [81] Agalave, S.G., Maujan, S.R., Pore, V.S., Click chemistry: 1,2,3-triazoles as pharmacophores. Chem. Asian J. 6 (2011), 2696–2718.
    • (2011) Chem. Asian J. , vol.6 , pp. 2696-2718
    • Agalave, S.G.1    Maujan, S.R.2    Pore, V.S.3
  • 82
    • 84877835595 scopus 로고    scopus 로고
    • Click chemistry for drug development and diverse chemical-biology applications
    • [82] Thirumurugan, P., Matosiuk, D., Jozwiak, K., Click chemistry for drug development and diverse chemical-biology applications. Chem. Rev. 113 (2013), 4905–4979.
    • (2013) Chem. Rev. , vol.113 , pp. 4905-4979
    • Thirumurugan, P.1    Matosiuk, D.2    Jozwiak, K.3
  • 83
    • 85043147568 scopus 로고    scopus 로고
    • Synthesis and derivatization of an ent-kaurane diterpenoid, Chinese Patent (2011) CN 102584760 A.
    • [83] F.J. Nan, Y.M. Zhang, H.N. Liu, J. Ding, L.H. Meng, C.H. Xu, Synthesis and derivatization of an ent-kaurane diterpenoid, Chinese Patent (2011) CN 102584760 A.
    • Nan, F.J.1    Zhang, Y.M.2    Liu, H.N.3    Ding, J.4    Meng, L.H.5    Xu, C.H.6
  • 84
    • 33646460405 scopus 로고    scopus 로고
    • Bisrubescensins A-C: three new dimeric ent-kauranoids isolated from Isodon rubescens
    • [84] Huang, S.X., Xiao, W.L., Li, L.M., Li, S.H., Zhou, Y., Ding, L.S., Lou, L.G., Sun, H.D., Bisrubescensins A-C: three new dimeric ent-kauranoids isolated from Isodon rubescens. Org. Lett. 8 (2006), 1157–1160.
    • (2006) Org. Lett. , vol.8 , pp. 1157-1160
    • Huang, S.X.1    Xiao, W.L.2    Li, L.M.3    Li, S.H.4    Zhou, Y.5    Ding, L.S.6    Lou, L.G.7    Sun, H.D.8
  • 86
    • 70350491038 scopus 로고    scopus 로고
    • ent-Kaurane and cembrane diterpenoids from Isodon sculponeatus and their cytotoxicity
    • [86] Li, L.M., Li, G.Y., Pu, J.X., Xiao, W.L., Ding, L.S., Sun, H.D., ent-Kaurane and cembrane diterpenoids from Isodon sculponeatus and their cytotoxicity. J. Nat. Prod. 72 (2009), 1851–1856.
    • (2009) J. Nat. Prod. , vol.72 , pp. 1851-1856
    • Li, L.M.1    Li, G.Y.2    Pu, J.X.3    Xiao, W.L.4    Ding, L.S.5    Sun, H.D.6
  • 88
    • 78650449672 scopus 로고    scopus 로고
    • 6,7-seco-ent-kaurane diterpenoids from Isodon sculponeatus with cytotoxic activity
    • [88] Li, X., Pu, J.X., Weng, Z.Y., Zhao, Y., Zhao, Y., Xiao, W.L., Sun, H.D., 6,7-seco-ent-kaurane diterpenoids from Isodon sculponeatus with cytotoxic activity. Chem. Biodivers. 7 (2010), 2888–2896.
    • (2010) Chem. Biodivers. , vol.7 , pp. 2888-2896
    • Li, X.1    Pu, J.X.2    Weng, Z.Y.3    Zhao, Y.4    Zhao, Y.5    Xiao, W.L.6    Sun, H.D.7
  • 89
    • 84860351057 scopus 로고    scopus 로고
    • The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents
    • [89] Wang, L., Li, D., Xu, S., Cai, H., Yao, H., Zhang, Y., Jiang, J., Xu, J., The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents. Eur. J. Med. Chem. 52 (2012), 242–250.
    • (2012) Eur. J. Med. Chem. , vol.52 , pp. 242-250
    • Wang, L.1    Li, D.2    Xu, S.3    Cai, H.4    Yao, H.5    Zhang, Y.6    Jiang, J.7    Xu, J.8
  • 90
    • 84871410742 scopus 로고    scopus 로고
    • Synthesis of spirolactone-type diterpenoid derivatives from kaurene-type oridonin with improved antiproliferative effects and their apoptosis-inducing activity in human hepatoma Bel-7402 cells
    • [90] Li, D., Cai, H., Jiang, B., Liu, G., Wang, Y., Wang, L., Yao, H., Wu, X., Sun, Y., Xu, J., Synthesis of spirolactone-type diterpenoid derivatives from kaurene-type oridonin with improved antiproliferative effects and their apoptosis-inducing activity in human hepatoma Bel-7402 cells. Eur. J. Med. Chem. 59 (2013), 322–328.
    • (2013) Eur. J. Med. Chem. , vol.59 , pp. 322-328
    • Li, D.1    Cai, H.2    Jiang, B.3    Liu, G.4    Wang, Y.5    Wang, L.6    Yao, H.7    Wu, X.8    Sun, Y.9    Xu, J.10
  • 91
    • 84877025427 scopus 로고    scopus 로고
    • Enmein-type diterpenoid analogs from natural kaurene-type oridonin: synthesis and their antitumor biological evaluation
    • [91] Li, D., Xu, S., Cai, H., Pei, L., Zhang, H., Wang, L., Yao, H., Wu, X., Jiang, J., Sun, Y., Xu, J., Enmein-type diterpenoid analogs from natural kaurene-type oridonin: synthesis and their antitumor biological evaluation. Eur. J. Med. Chem. 64 (2013), 215–221.
    • (2013) Eur. J. Med. Chem. , vol.64 , pp. 215-221
    • Li, D.1    Xu, S.2    Cai, H.3    Pei, L.4    Zhang, H.5    Wang, L.6    Yao, H.7    Wu, X.8    Jiang, J.9    Sun, Y.10    Xu, J.11
  • 92
    • 84877020396 scopus 로고    scopus 로고
    • Library construction and biological evaluation of enmein-type diterpenoid analogues as potential anticancer agents
    • [92] Li, D., Xu, S., Cai, H., Pei, L., Wang, L., Wu, X., Yao, H., Jiang, J., Sun, Y., Xu, J., Library construction and biological evaluation of enmein-type diterpenoid analogues as potential anticancer agents. ChemMedChem 8 (2013), 812–818.
    • (2013) ChemMedChem , vol.8 , pp. 812-818
    • Li, D.1    Xu, S.2    Cai, H.3    Pei, L.4    Wang, L.5    Wu, X.6    Yao, H.7    Jiang, J.8    Sun, Y.9    Xu, J.10
  • 93
    • 3042577557 scopus 로고    scopus 로고
    • Rubescensins S and T: seco-ent-kaurane diterpenoids from Isodon rubescens var. taihangensis
    • [93] Han, Q., Li, R., Zhang, J., Sun, H., Rubescensins S and T: seco-ent-kaurane diterpenoids from Isodon rubescens var. taihangensis. Helv. Chim. Acta 87 (2004), 1119–1124.
    • (2004) Helv. Chim. Acta , vol.87 , pp. 1119-1124
    • Han, Q.1    Li, R.2    Zhang, J.3    Sun, H.4
  • 94
    • 79957979055 scopus 로고    scopus 로고
    • Synthesis and revision of stereochemistry of rubescensin S
    • [94] Zhang, M., Zhang, Y., Lu, W., Nan, F.J., Synthesis and revision of stereochemistry of rubescensin S. Org. Biomol. Chem. 9 (2011), 4436–4439.
    • (2011) Org. Biomol. Chem. , vol.9 , pp. 4436-4439
    • Zhang, M.1    Zhang, Y.2    Lu, W.3    Nan, F.J.4
  • 97
    • 34247360358 scopus 로고    scopus 로고
    • Back to the future of oridonin: again, compound from medicinal herb shows potent antileukemia efficacies in vitro and in vivo
    • [97] Zhou, G.B., Chen, S.J., Wang, Z.Y., Chen, Z., Back to the future of oridonin: again, compound from medicinal herb shows potent antileukemia efficacies in vitro and in vivo. Cell Res. 17 (2007), 274–276.
    • (2007) Cell Res. , vol.17 , pp. 274-276
    • Zhou, G.B.1    Chen, S.J.2    Wang, Z.Y.3    Chen, Z.4
  • 98
    • 54249155522 scopus 로고    scopus 로고
    • Network pharmacology: the next paradigm in drug discovery
    • [98] Hopkins, A.L., Network pharmacology: the next paradigm in drug discovery. Nat. Chem. Biol. 4 (2008), 682–690.
    • (2008) Nat. Chem. Biol. , vol.4 , pp. 682-690
    • Hopkins, A.L.1
  • 100
    • 75149130051 scopus 로고    scopus 로고
    • Targeting the cancer kinome through polypharmacology
    • [100] Knight, Z.A., Lin, H., Shokat, K.M., Targeting the cancer kinome through polypharmacology. Nat. Rev. Cancer 10 (2010), 130–137.
    • (2010) Nat. Rev. Cancer , vol.10 , pp. 130-137
    • Knight, Z.A.1    Lin, H.2    Shokat, K.M.3
  • 101
    • 84937713453 scopus 로고    scopus 로고
    • Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products
    • [101] Kibble, M., Saarinen, N., Tang, J., Wennerberg, K., Makela, S., Aittokallio, T., Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products. Nat. Prod. Rep. 32 (2015), 1249–1266.
    • (2015) Nat. Prod. Rep. , vol.32 , pp. 1249-1266
    • Kibble, M.1    Saarinen, N.2    Tang, J.3    Wennerberg, K.4    Makela, S.5    Aittokallio, T.6
  • 103
    • 84978640737 scopus 로고    scopus 로고
    • A new oridonin analogue suppresses triple-negative breast cancer cells and tumor growth via the induction of death receptor 5
    • in press
    • [103] Wu, J., Ding, Y., Zhou, Z., Ding, C., Chen, H., Zhou, J., Chen, C., A new oridonin analogue suppresses triple-negative breast cancer cells and tumor growth via the induction of death receptor 5. Cancer Lett., 2016 in press.
    • (2016) Cancer Lett.
    • Wu, J.1    Ding, Y.2    Zhou, Z.3    Ding, C.4    Chen, H.5    Zhou, J.6    Chen, C.7
  • 104
    • 84930915706 scopus 로고    scopus 로고
    • Targeting Kruppel-like factor 5 (KLF5) for cancer therapy
    • [104] Gao, Y., Ding, Y., Chen, H., Chen, H., Zhou, J., Targeting Kruppel-like factor 5 (KLF5) for cancer therapy. Curr. Top. Med. Chem. 15 (2015), 699–713.
    • (2015) Curr. Top. Med. Chem. , vol.15 , pp. 699-713
    • Gao, Y.1    Ding, Y.2    Chen, H.3    Chen, H.4    Zhou, J.5
  • 106
    • 84971607463 scopus 로고    scopus 로고
    • Probing the anticancer action of oridonin with fluorescent analogues: visualizing subcellular localization to mitochondria
    • [106] Xu, S., Luo, S., Yao, H., Cai, H., Miao, X., Wu, F., Yang, D.H., Wu, X., Xie, W., Yao, H., Chen, Z.S., Xu, J., Probing the anticancer action of oridonin with fluorescent analogues: visualizing subcellular localization to mitochondria. J. Med. Chem. 59 (2016), 5022–5034.
    • (2016) J. Med. Chem. , vol.59 , pp. 5022-5034
    • Xu, S.1    Luo, S.2    Yao, H.3    Cai, H.4    Miao, X.5    Wu, F.6    Yang, D.H.7    Wu, X.8    Xie, W.9    Yao, H.10    Chen, Z.S.11    Xu, J.12
  • 107
    • 84921533887 scopus 로고    scopus 로고
    • Evolutions in fragment-based drug design: the deconstruction-reconstruction approach
    • [107] Chen, H., Zhou, X., Wang, A., Zheng, Y., Gao, Y., Zhou, J., Evolutions in fragment-based drug design: the deconstruction-reconstruction approach. Drug Discov. Today 20 (2015), 105–113.
    • (2015) Drug Discov. Today , vol.20 , pp. 105-113
    • Chen, H.1    Zhou, X.2    Wang, A.3    Zheng, Y.4    Gao, Y.5    Zhou, J.6
  • 108
    • 84876079596 scopus 로고    scopus 로고
    • Fragment informatics and computational fragment-based drug design: an overview and update
    • [108] Sheng, C., Zhang, W., Fragment informatics and computational fragment-based drug design: an overview and update. Med. Res. Rev. 33 (2013), 554–598.
    • (2013) Med. Res. Rev. , vol.33 , pp. 554-598
    • Sheng, C.1    Zhang, W.2
  • 109
    • 33847381100 scopus 로고    scopus 로고
    • A decade of fragment-based drug design: strategic advances and lessons learned
    • [109] Hajduk, P.J., Greer, J., A decade of fragment-based drug design: strategic advances and lessons learned. Nat. Rev. Drug Discov. 6 (2007), 211–219.
    • (2007) Nat. Rev. Drug Discov. , vol.6 , pp. 211-219
    • Hajduk, P.J.1    Greer, J.2
  • 110
    • 84873738776 scopus 로고    scopus 로고
    • Fragment-based drug design and identification of HJC0123, a novel orally bioavailable STAT3 inhibitor for cancer therapy
    • [110] Chen, H., Yang, Z., Ding, C., Chu, L., Zhang, Y., Terry, K., Liu, H., Shen, Q., Zhou, J., Fragment-based drug design and identification of HJC0123, a novel orally bioavailable STAT3 inhibitor for cancer therapy. Eur. J. Med. Chem. 62 (2013), 498–507.
    • (2013) Eur. J. Med. Chem. , vol.62 , pp. 498-507
    • Chen, H.1    Yang, Z.2    Ding, C.3    Chu, L.4    Zhang, Y.5    Terry, K.6    Liu, H.7    Shen, Q.8    Zhou, J.9
  • 111
    • 84873873454 scopus 로고    scopus 로고
    • A combined bioinformatics and chemoinformatics approach for developing asymmetric bivalent AMPA receptor positive allosteric modulators as neuroprotective agents
    • [111] Chen, H., Wang, C.Z., Ding, C., Wild, C., Copits, B., Swanson, G.T., Johnson, K.M., Zhou, J., A combined bioinformatics and chemoinformatics approach for developing asymmetric bivalent AMPA receptor positive allosteric modulators as neuroprotective agents. ChemMedChem 8 (2013), 226–230.
    • (2013) ChemMedChem , vol.8 , pp. 226-230
    • Chen, H.1    Wang, C.Z.2    Ding, C.3    Wild, C.4    Copits, B.5    Swanson, G.T.6    Johnson, K.M.7    Zhou, J.8
  • 112
    • 84902175603 scopus 로고    scopus 로고
    • Discovery of potent anticancer agent HJC0416, an orally bioavailable small molecule inhibitor of signal transducer and activator of transcription 3 (STAT3)
    • [112] Chen, H., Yang, Z., Ding, C., Xiong, A., Wild, C., Wang, L., Ye, N., Cai, G., Flores, R.M., Ding, Y., Shen, Q., Zhou, J., Discovery of potent anticancer agent HJC0416, an orally bioavailable small molecule inhibitor of signal transducer and activator of transcription 3 (STAT3). Eur. J. Med. Chem. 82 (2014), 195–203.
    • (2014) Eur. J. Med. Chem. , vol.82 , pp. 195-203
    • Chen, H.1    Yang, Z.2    Ding, C.3    Xiong, A.4    Wild, C.5    Wang, L.6    Ye, N.7    Cai, G.8    Flores, R.M.9    Ding, Y.10    Shen, Q.11    Zhou, J.12
  • 113
    • 84929377653 scopus 로고    scopus 로고
    • pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures
    • [113] Pires, D.E., Blundell, T.L., Ascher, D.B., pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 58 (2015), 4066–4072.
    • (2015) J. Med. Chem. , vol.58 , pp. 4066-4072
    • Pires, D.E.1    Blundell, T.L.2    Ascher, D.B.3
  • 114
    • 84873252557 scopus 로고    scopus 로고
    • Liposomal drug delivery systems: from concept to clinical applications
    • [114] Allen, T.M., Cullis, P.R., Liposomal drug delivery systems: from concept to clinical applications. Adv. Drug Deliv. Rev. 65 (2013), 36–48.
    • (2013) Adv. Drug Deliv. Rev. , vol.65 , pp. 36-48
    • Allen, T.M.1    Cullis, P.R.2
  • 116
    • 84866772465 scopus 로고    scopus 로고
    • Oridonin nanosuspension was more effective than free oridonin on G2/M cell cycle arrest and apoptosis in the human pancreatic cancer PANC-1 cell line
    • [116] Qi, X., Zhang, D., Xu, X., Feng, F., Ren, G., Chu, Q., Zhang, Q., Tian, K., Oridonin nanosuspension was more effective than free oridonin on G2/M cell cycle arrest and apoptosis in the human pancreatic cancer PANC-1 cell line. Int. J. Nanomed. 7 (2012), 1793–1804.
    • (2012) Int. J. Nanomed. , vol.7 , pp. 1793-1804
    • Qi, X.1    Zhang, D.2    Xu, X.3    Feng, F.4    Ren, G.5    Chu, Q.6    Zhang, Q.7    Tian, K.8
  • 118
    • 79952117065 scopus 로고    scopus 로고
    • Effects of oridonin nanosuspension on cell proliferation and apoptosis of human prostatic carcinoma PC-3 cell line
    • [118] Zhang, Z., Zhang, X., Xue, W., Yangyang, Y., Xu, D., Zhao, Y., Lou, H., Effects of oridonin nanosuspension on cell proliferation and apoptosis of human prostatic carcinoma PC-3 cell line. Int. J. Nanomed. 5 (2010), 735–742.
    • (2010) Int. J. Nanomed. , vol.5 , pp. 735-742
    • Zhang, Z.1    Zhang, X.2    Xue, W.3    Yangyang, Y.4    Xu, D.5    Zhao, Y.6    Lou, H.7
  • 119
    • 84863040835 scopus 로고    scopus 로고
    • RGD-modified poly(D,L-lactic acid) nanoparticles enhance tumor targeting of oridonin
    • [119] Xu, J., Zhao, J.H., Liu, Y., Feng, N.P., Zhang, Y.T., RGD-modified poly(D,L-lactic acid) nanoparticles enhance tumor targeting of oridonin. Int. J. Nanomed. 7 (2012), 211–219.
    • (2012) Int. J. Nanomed. , vol.7 , pp. 211-219
    • Xu, J.1    Zhao, J.H.2    Liu, Y.3    Feng, N.P.4    Zhang, Y.T.5
  • 121
    • 41349120910 scopus 로고    scopus 로고
    • Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions
    • [121] Gao, L., Zhang, D., Chen, M., Duan, C., Dai, W., Jia, L., Zhao, W., Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions. Int. J. Pharm. 355 (2008), 321–327.
    • (2008) Int. J. Pharm. , vol.355 , pp. 321-327
    • Gao, L.1    Zhang, D.2    Chen, M.3    Duan, C.4    Dai, W.5    Jia, L.6    Zhao, W.7
  • 122
    • 41349096647 scopus 로고    scopus 로고
    • Preparation and evaluation of self-microemulsifying drug delivery system of oridonin
    • [122] Zhang, P., Liu, Y., Feng, N., Xu, J., Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. Int. J. Pharm. 355 (2008), 269–276.
    • (2008) Int. J. Pharm. , vol.355 , pp. 269-276
    • Zhang, P.1    Liu, Y.2    Feng, N.3    Xu, J.4
  • 123
    • 57049152323 scopus 로고    scopus 로고
    • Optimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridonin
    • [123] Liu, Y., Zhang, P., Feng, N., Zhang, X., Wu, S., Zhao, J., Optimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridonin. Int. J. Pharm. 365 (2009), 136–142.
    • (2009) Int. J. Pharm. , vol.365 , pp. 136-142
    • Liu, Y.1    Zhang, P.2    Feng, N.3    Zhang, X.4    Wu, S.5    Zhao, J.6
  • 124
    • 84867055462 scopus 로고    scopus 로고
    • Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease
    • [124] Liby, K.T., Sporn, M.B., Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease. Pharmacol. Rev. 64 (2012), 972–1003.
    • (2012) Pharmacol. Rev. , vol.64 , pp. 972-1003
    • Liby, K.T.1    Sporn, M.B.2
  • 125
    • 34247526984 scopus 로고    scopus 로고
    • Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer
    • [125] Liby, K.T., Yore, M.M., Sporn, M.B., Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat. Rev. Cancer 7 (2007), 357–369.
    • (2007) Nat. Rev. Cancer , vol.7 , pp. 357-369
    • Liby, K.T.1    Yore, M.M.2    Sporn, M.B.3
  • 126
    • 84908400222 scopus 로고    scopus 로고
    • Synthesis and antimycobacterial evaluation of natural oridonin and its enmein-type derivatives
    • [126] Xu, S., Pei, L., Li, D., Yao, H., Cai, H., Yao, H., Wu, X., Xu, J., Synthesis and antimycobacterial evaluation of natural oridonin and its enmein-type derivatives. Fitoterapia 99 (2014), 300–306.
    • (2014) Fitoterapia , vol.99 , pp. 300-306
    • Xu, S.1    Pei, L.2    Li, D.3    Yao, H.4    Cai, H.5    Yao, H.6    Wu, X.7    Xu, J.8
  • 127
    • 84901793595 scopus 로고    scopus 로고
    • Design, synthesis and antimycobacterial activity evaluation of natural oridonin derivatives
    • [127] Xu, S., Li, D., Pei, L., Yao, H., Wang, C., Cai, H., Yao, H., Wu, X., Xu, J., Design, synthesis and antimycobacterial activity evaluation of natural oridonin derivatives. Bioorg. Med. Chem. Lett. 24 (2014), 2811–2814.
    • (2014) Bioorg. Med. Chem. Lett. , vol.24 , pp. 2811-2814
    • Xu, S.1    Li, D.2    Pei, L.3    Yao, H.4    Wang, C.5    Cai, H.6    Yao, H.7    Wu, X.8    Xu, J.9
  • 130
    • 84941190738 scopus 로고    scopus 로고
    • Molecular insight in the multifunctional effects of oridonin
    • [130] Owona, B.A., Schluesener, H.J., Molecular insight in the multifunctional effects of oridonin. Drugs R. D. 15 (2015), 233–244.
    • (2015) Drugs R. D. , vol.15 , pp. 233-244
    • Owona, B.A.1    Schluesener, H.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.